Indeterminate; high risk of being a follicular tumor, often requiring surgery to differentiate.
This system is currently in its second edition (2023) and is a standard tool in cytopathology . If you'd like, I can provide: The Bethesda System for Reporting Thyroid Cytop...
Before this system was finalized (originally around 2010 and updated in 2023), different laboratories used different terms to describe thyroid fine-needle aspiration (FNA) samples, causing confusion for clinicians. The Bethesda System was developed through an NIH-sponsored conference to create a common language. Indeterminate; high risk of being a follicular tumor,
Each category helps clinicians understand the likelihood of malignancy to guide treatment (e.g., surveillance vs. surgery). The Bethesda System was developed through an NIH-sponsored
High probability of cancer; often leads to surgery. VI: Malignant: Confirmed cancer cells. Key Benefits
It ensures that a "suspicious" result means the same thing, regardless of which lab processed it.